Skip to main content

Find Clinical Trials

Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131

NCT01296204

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Centre René Gauducheau Nantes, France

Moreau Nantes, France

View Trial Details

Completed

Quality of Life in Patients With Multiple Myeloma

NCT00290095

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Ullevaal University Hospital Oslo, Norway

View Trial Details

Completed

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

NCT00646139

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +53 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

NCT00772811

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +23 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

NCT01296503

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hospital Universitário Clementino Fraga Filho Rio de Janeiro, Brazil

Universidade Estadual de Campinas Campinas, São Paulo, Brazil

Universidade de São Paulo- Ribeirão Preto Ribeirão Preto, São Paulo, Brazil

Santa Casa de Misericórdia de São Paulo São Paulo, Brazil

View Trial Details

Completed

Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma

NCT00185653

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma

NCT00602511

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Ålborg university Hospital Aalborg, Denmark

Århus University Hospital Aarhus, Denmark

Rigshospitalet Copenhagen, Denmark

Herlev University Hospital Herlev, Denmark

View all 27 locations

View Trial Details

Completed

Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates

NCT00104650

Conditions: Blood Protein Disorders, Bone Metastases in Men With Hormone-Refractory Prostate Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, +15 more
Locations: Not specified

View Trial Details

Completed

A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

NCT01274403

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Gruppo Italiano Studio Linfoma Modena, Italy

View Trial Details

Completed

Velcade-Melphalan-Prednisone in Older Untreated Multiple Myeloma Patients.

NCT00388635

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Hospital Clínic Barcelona, Spain

Hospital de la Santa Creu i Sant Pau Barcelona, Spain

Hospital Germans Trias i Pujol Barcelona, Spain

Hospital Universitario de Canarias Santa Cruz de Tenerife, Canary Islands, Spain

View all 19 locations

View Trial Details